The present disclosure relates to polymers, methods for polymer synthesis, and methods of modifying the backbone of said polymers. Modification of the polymer backbone via a sigmatropic rearrangement allows facile entry into new, highly ordered polymers.

Rubber compounds may comprise: an epoxidized polypentenamer rubber (CPR) and/or a hydrolyzed epoxidized CPR; and a filler comprising silica particles. One nonlimiting example is rubber compound comprising: phr to 90 phr of a styrene-butadiene rubber (SBR), a natural rubber (NR), and/or a butadiene rubber (BR); 10 phr to 50 phr of a epoxidized CPR and/or a hydrolyzed epoxidized CPR; and 10 phr to 200 phr of a filler comprising silica particles, wherein the SBR, the NR, the BR, the epoxidized CPR, and the hydrolyzed epoxidized CPR combined equal 100 parts. Rubber compounds comprising epoxidized CPR and/or a hydrolyzed epoxidized CPR; and a filler comprising silica particles may be useful in tire compositions.

The present disclosure provides, in some aspects, macromonomers of Formula (I), and salts thereof; methods of preparing the macromonomers, and salts thereof; Brush prodrugs (polymers); methods of preparing the Brush prodrugs; compounds of Formula (II); conjugates of Formula (III), and salts thereof; pharmaceutical compositions comprising a Brush prodrug, or a conjugate or a salt thereof; kits comprising: a macromonomer or a salt thereof, a Brush prodrug, a compound, a conjugate or a salt thereof, or a pharmaceutical composition; methods of using the Brush prodrugs, or conjugates or salts thereof; and uses of the Brush prodrugs, and conjugates or salts thereof. These chemical entities may be useful in delivering pharmaceutical agents to a subject or cell.

The present disclosure relates to polymers, methods for polymer synthesis, and methods of modifying the backbone of said polymers. Modification of the polymer backbone via a sigmatropic rearrangement allows facile entry into new, highly ordered polymers.

Provided herein are compositions and methods of making and using drug-binding polymers or nanoparticles for targeted therapies. In some embodiments the drug-binding polymers or nanoparticles can deliver two or more of an antibiotic, an alkali or transition metal cation, or anticancer agents.

The invention relates to compositions comprising at least one cyclic olefin monomer, optionally at least one linear olefin monomer, at least one thermoplastic hydrocarbon resin, and at least one olefin metathesis catalyst. The invention also relates to articles of manufacture made from the compositions of the invention, and methods of making the articles. The invention also relates to coating compositions comprising the compositions of the invention, and to objects or substrates coated with the coating compositions of the invention, which may then be cured. The invention also relates to methods of coating the objects or substrates with the coating compositions of the invention. The invention further relates to the use of the compositions of the invention as adhesives.

The invention provides: imidazole and imidazolium compounds of formulas (I) and (II): ##STR00001##
polymers containing a plurality of imidazolium-containing repeating units of formula (III): ##STR00002##
and membranes and devices comprising the polymers. Also provided are methods of making the inventive compounds and polymers.

Provided is a resin that can simultaneously achieve a high refractive index, high heat resistance, and low birefringence. A hydrogenated cycloolefin copolymer is obtained through hydrogenation of a cycloolefin copolymer that includes a structural unit derived from 1-naphthylnorbornene and a structural unit derived from 2-naphthylnorbornene, wherein an average endo isomer ratio of the 1-naphthylnorbornene and the 2-naphthylnorbornene is 50 mol % or more. The hydrogenated cycloolefin copolymer is suitable for use as a material of an optical element such as an optical lens.